ldtЛучевая диагностика и терапияDiagnostic radiology and radiotherapy2079-5343Baltic Medical Education Center10.22328/2079-5343-2020-11-1-78-92ldt-480Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL RESEARCHСравнение диагностической эффективности магнитно-резонансной томографии с диффузионно-взвешенным исследованием всего тела и позитронной эмиссионной томографии/компьютерной томографии при определении степени регрессии лимфомы после завершения химиотерапии: Минская шкала и шкала ДовильComparison of the diagnostic effectiveness of whole body magnetic resonance imaging with diffusion weighted imaging and positron emission tomography/computed tomography in determining tumor response in lymphoma after the end of chemotherapy: Minsk scaleand Deauville scalehttps://orcid.org/0000-0002-0010-8324ХоружикС. А.KharuzhykS. A.

Хоружик Сергей Анатольевич — кандидат медицинских наук, доцент, врач МРТ рентгеновского отделения. SPIN-код: 8797–1020

223040, Минский район, агр. Лесной

Siarhei A. Kharuzhyk

Minsk

skharuzhyk@nld.byhttps://orcid.org/0000-0003-2194-4820ЖавридЭ. А.ZhavridE. A.

Жаврид Эдвард Антонович — доктор медицинских наук, профессор, главный научный сотрудник лаборатории фотодинамической терапии и гипертермии с группой химиотерапии. SPIN-код: 9658–0969

223040, Минский район, агр. Лесной

Edward A. Zhavrid

Minsk

e.zhavrid@gmail.comhttps://orcid.org/0000-0002-3209-0114ДзюбанА. В.DziubanA. V.

Дзюбан Андрей Валентинович — врач-рентгенолог отделения ПЭТ

223040, Минский район, агр. Лесной

Andrei V. Dziuban

Minsk

Adzuban@mail.ruhttps://orcid.org/0000-0002-8772-8912СуколинскаяЕ. В.SukolinskajaE. V.

Суколинская Елена Владимировна — кандидат медицинских наук, ведущий научный сотрудник лаборатории фотодинамической терапии и гипертермии с группой химиотерапии

223040, Минский район, агр. Лесной

Elena V. Sukolinskaja

Minsk

e.suvelena@gmail.comhttps://orcid.org/0000-0001-8629-2830КаленикО. А.KalenikO. A.

Каленик Ольга Александровна — кандидат медицинских наук, научный сотрудник лаборатории фотодинамической терапии и гипертермии с группой химиотерапии

223040, Минский район, агр. Лесной

Olga A. Kalenik

Minsk

olga.a.kalenik@mail.ruРеспубликанский научно-практический центр онкологии и медицинской радиологии им. Н. Н. АлександроваБеларусьRepublican Scientific and Practical Center of Oncology and Medical Radiology named for N. N. AlexandrovBelarus2020010420201117892Copyright © Хоружик С.А., Жаврид Э.А., Дзюбан А.В., Суколинская Е.В., Каленик О.А., 20202020Хоружик С.А., Жаврид Э.А., Дзюбан А.В., Суколинская Е.В., Каленик О.А.Kharuzhyk S.A., Zhavrid E.A., Dziuban A.V., Sukolinskaja E.V., Kalenik O.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://radiag.bmoc-spb.ru/jour/article/view/480лимфомадиффузионно-взвешенная магнитно-резонансная томографияпозитронная эмиссионная томография/компьютерная томографияоценка регрессии опухолейlymphomadiffusion-weighted magnetic resonance imagingpositron emission tomography/computed tomographytumor responsee valuationReferencesCheson B.D., Fisher R.I., Barrington S.F., Cavalli F., Schwartz L.H., Zucca E., Lister T.A. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification // J. Clin. Oncol. 2014. Vol. 32. P. 3059–3068. https://doi.org/10.1200/JCO.2013.54.8800.Cheson B.D., Fisher R.I., Barrington S.F., Cavalli F., Schwartz L.H., Zucca E., Lister T.A. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification // J. Clin. Oncol. 2014. Vol. 32. P. 3059–3068. https://doi.org/10.1200/JCO.2013.54.8800.Хоружик С.А., Жаврид Э.А., Сачивко Н.В. Сравнение диагностической эффективности рентгеновской компьютерной томографии, магнитно-резонансной томографии и диффузионно-взвешенной магнитно-резонансной томографии при дифференциации остаточных опухолей и образований посттерапевтического характера у пациентов с лимфомами после завершения лечения // Онкогематология. 2016. № 3. С. 40–48. https://doi.org/10.17650/1818-8346-2016-11-3-40-48.Kharuzhyk S.A., Zhavrid E.A., Sachivko N.V. Comparison of diagnostic effectiveness of X-ray computed tomography, magnetic resonance imaging and diffusion-weighted magnetic resonance imaging in the differentiation of residual tumors and postherapeutic masses in patients with lymphoma after treatment. Oncohematology, 2016, No. 3, рр. 40–48. (In Russ.) https://doi.org/10.17650/1818-8346-2016-11-3-40-48.Padhani A.R., Lecouvet F.E., Tunariu N., Koh D.M., De Keyzer F., Collins D.J., Sala E., Schlemmer H.P., Petralia G., Vargas H.A., Fanti S., Tombal H.B., de Bono J. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer // Eur. Urol. 2017. Vol. 71. P. 81–92. https://doi.org/10.1016/j.eururo.2016.05.033.Padhani A.R., Lecouvet F.E., Tunariu N., Koh D.M., De Keyzer F., Collins D.J., Sala E., Schlemmer H.P., Petralia G., Vargas H.A., Fanti S., Tombal H.B., de Bono J. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer // Eur. Urol. 2017. Vol. 71. P. 81–92. https://doi.org/10.1016/j.eururo.2016.05.033.Lecouvet F.E, Talbot J.N., Messiou C., Bourguet P., Liu Y., de Souza N.M. Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group // Eur. J. Cancer. 2014. Vol. 50. P. 2519–2531. https://doi.org/10.1016/j.ejca.2014.07.002.Lecouvet F.E, Talbot J.N., Messiou C., Bourguet P., Liu Y., de Souza N.M. Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group // Eur. J. Cancer. 2014. Vol. 50. P. 2519–2531. https://doi.org/10.1016/j.ejca.2014.07.002.Dimopoulos M.A., Hillengass J., Usmani S., Zamagni E., Lentzsch S., Davies F.E., Raje N., Sezer O., Zweegman S., Shah J., Badros A., Shimizu K., Moreau P., Chim C.S., Lahuerta J.J., Hou J., Jurczyszyn A., Goldschmidt H., Sonneveld P., Palumbo A., Ludwig H., Cavo M., Barlogie B., Anderson K., Roodman G.D., Rajkumar S.V., Durie B.G., Terpos E. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement // J. Clin. Oncol. 2015. Vol. 33. P. 657–664. https://doi.org/10.1200/JCO.2014.57.9961.Dimopoulos M.A., Hillengass J., Usmani S., Zamagni E., Lentzsch S., Davies F.E., Raje N., Sezer O., Zweegman S., Shah J., Badros A., Shimizu K., Moreau P., Chim C.S., Lahuerta J.J., Hou J., Jurczyszyn A., Goldschmidt H., Sonneveld P., Palumbo A., Ludwig H., Cavo M., Barlogie B., Anderson K., Roodman G.D., Rajkumar S.V., Durie B.G., Terpos E. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement // J. Clin. Oncol. 2015. Vol. 33. P. 657–664. https://doi.org/10.1200/JCO.2014.57.9961.Barnes A., Alonzi R., Blackledge M., Charles-Edwards G., Collins DJ., Cook G., Coutts G., Goh V., Graves M., Kelly C., Koh DM., McCallum H., Miquel M.E., O’Connor J., Padhani A., Pearson R., Priest A., Rockall A., Stirling J., Taylor S., Tunariu N. van der Meulen J., Walls D., Winfield J., Punwani S. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer // Br. J. Radiol. 2018. Vol. 91. P. 20170577. https://doi.org/10.1259/bjr.20170577.Barnes A., Alonzi R., Blackledge M., Charles-Edwards G., Collins DJ., Cook G., Coutts G., Goh V., Graves M., Kelly C., Koh DM., McCallum H., Miquel M.E., O’Connor J., Padhani A., Pearson R., Priest A., Rockall A., Stirling J., Taylor S., Tunariu N. van der Meulen J., Walls D., Winfield J., Punwani S. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer // Br. J. Radiol. 2018. Vol. 91. P. 20170577. https://doi.org/10.1259/bjr.20170577.De Souza N.M., Winfield J.M., Waterton J.C., Weller A., Papoutsaki M.V., Doran S.J., Collins D.J., Fournier L., Sullivan D., Chenevert T., Jackson A., Boss M., Trattnig S., Liu Y. Implementing diffusion-weighted MRI for body imaging in prospective multicenter trials: current considerations and future perspectives // Eur. Radiol. 2018. Vol. 28. P. 1118–1131. https://doi.org/10.1007/s00330-017-4972-z.De Souza N.M., Winfield J.M., Waterton J.C., Weller A., Papoutsaki M.V., Doran S.J., Collins D.J., Fournier L., Sullivan D., Chenevert T., Jackson A., Boss M., Trattnig S., Liu Y. Implementing diffusion-weighted MRI for body imaging in prospective multicenter trials: current considerations and future perspectives // Eur. Radiol. 2018. Vol. 28. P. 1118–1131. https://doi.org/10.1007/s00330-017-4972-z.Taouli B., Beer A.J., Chenevert T., Collins D., Lehman C., Matos C., Padhani A.R., Rosenkrantz A.B., Shukla-Dave A., Sigmund E., Tanenbaum L., Thoeny H., Thomassin-Naggara I., Barbieri S., CorcueraSolano I., Orton M., Partridge S.C., Koh D.M. Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop // J. Magn. Reson. Imaging. 2016. Vol. 44. P. 521–540. https://doi.org/10.1002/jmri.25196.Taouli B., Beer A.J., Chenevert T., Collins D., Lehman C., Matos C., Padhani A.R., Rosenkrantz A.B., Shukla-Dave A., Sigmund E., Tanenbaum L., Thoeny H., Thomassin-Naggara I., Barbieri S., CorcueraSolano I., Orton M., Partridge S.C., Koh D.M. Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshop // J. Magn. Reson. Imaging. 2016. Vol. 44. P. 521–540. https://doi.org/10.1002/jmri.25196.Albano D., Patti C., La Grutta L., Agnello F., Grassedonio E., Mulè A., et al. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas // Eur. J. Radiol. 2016. Vol. 85. P. 313–318. https://doi.org/10.1016/j.ejrad.2015.Albano D., Patti C., La Grutta L., Agnello F., Grassedonio E., Mulè A., et al. Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas // Eur. J. Radiol. 2016. Vol. 85. P. 313–318. https://doi.org/10.1016/j.ejrad.2015.Maggialetti N., Ferrari C., Minoia C., Asabella A.N., Ficco M., Loseto G., De Tullio G., de Fazio V., Calabrese A., Guarini A., Rubini G., Brunese L. Role of WB-MR/DWIBS compared to 18 F-FDG PET/CT in the therapy response assessment of lymphoma // Radiol. Med. 2016. Vol. 121. P. 132–143. https://doi.org/10.1007/s11547-015-0581-6.Maggialetti N., Ferrari C., Minoia C., Asabella A.N., Ficco M., Loseto G., De Tullio G., de Fazio V., Calabrese A., Guarini A., Rubini G., Brunese L. Role of WB-MR/DWIBS compared to 18 F-FDG PET/CT in the therapy response assessment of lymphoma // Radiol. Med. 2016. Vol. 121. P. 132–143. https://doi.org/10.1007/s11547-015-0581-6.Herrmann K., Queiroz M., Huellner M.W., de Galiza Barbosa F., Buck A., Schaefer N., Stolzman P., Veit-Haibach P. Diagnostic performance of FDGPET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT // BMC Cancer. 2015. Vol. 15. P. 1002. https://doi.org/10.1186/s12885-015-2009-z.Herrmann K., Queiroz M., Huellner M.W., de Galiza Barbosa F., Buck A., Schaefer N., Stolzman P., Veit-Haibach P. Diagnostic performance of FDGPET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT // BMC Cancer. 2015. Vol. 15. P. 1002. https://doi.org/10.1186/s12885-015-2009-z.Mayerhoefer M.E., Karanikas G., Kletter K., Prosch H., Kiesewetter B., Skrabs C., Porpaczy E., Weber M., Knogler T., Sillaber C., Jaeger U., Simonitsch-Klupp I., Ubl P., Müllauer L., Dolak W., Lukas J., Raderer M. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18 F-FDGPET/CT-Controlled Prospective Study in 64 Patients // Clin. Cancer Res. 2015. Vol. 21. P. 2506–2513. https://doi.org/10.1158/1078-0432.CCR-14-2454.Mayerhoefer M.E., Karanikas G., Kletter K., Prosch H., Kiesewetter B., Skrabs C., Porpaczy E., Weber M., Knogler T., Sillaber C., Jaeger U., Simonitsch-Klupp I., Ubl P., Müllauer L., Dolak W., Lukas J., Raderer M. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18 F-FDGPET/CT-Controlled Prospective Study in 64 Patients // Clin. Cancer Res. 2015. Vol. 21. P. 2506–2513. https://doi.org/10.1158/1078-0432.CCR-14-2454.Littooij A.S., Kwee T.C., de Keizer B., Bruin M.C., Coma A., Beek F.J., Fijnheer R., Nievelstein R.A. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study // J. Magn. Reson. Imaging. 2015. Vol. 42. P. 1646–1655. https://doi.org/10.1002/jmri.24938.Littooij A.S., Kwee T.C., de Keizer B., Bruin M.C., Coma A., Beek F.J., Fijnheer R., Nievelstein R.A. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study // J. Magn. Reson. Imaging. 2015. Vol. 42. P. 1646–1655. https://doi.org/10.1002/jmri.24938.Meignan M., Gallamini A., Meignan M., Gallamini A., Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma // Leuk. Lymphoma. 2009. Vol. 50. P. 1257–1260. https://doi.org/10.1080/10428190903040048.Meignan M., Gallamini A., Meignan M., Gallamini A., Haioun C. Report on the First International Workshop on Interim-PET-Scan in Lymphoma // Leuk. Lymphoma. 2009. Vol. 50. P. 1257–1260. https://doi.org/10.1080/10428190903040048.Meignan M., Itti E., Gallamini A., Younes A. FDG PET/CT imaging as a biomarker in lymphoma // Eur. J. Nucl. Med. Mol. Imaging. 2015. Vol. 42. P. 623–633. https://doi.org/10.1007/s00259-014-2973-6.Meignan M., Itti E., Gallamini A., Younes A. FDG PET/CT imaging as a biomarker in lymphoma // Eur. J. Nucl. Med. Mol. Imaging. 2015. Vol. 42. P. 623–633. https://doi.org/10.1007/s00259-014-2973-6.Barrington S.F., Mikhaeel N.G., Kostakoglu L., Meignan M., Hutchings M., Müeller S.P., Schwartz L.H., Zucca E., Fisher R.I., Trotman J., Hoekstra O.S., Hicks R.J., O’Doherty M.J., Hustinx R., Biggi A., Cheson B.D. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group // J. Clin. Oncol. 2014. Vol. 32. P. 3048–3058.Barrington S.F., Mikhaeel N.G., Kostakoglu L., Meignan M., Hutchings M., Müeller S.P., Schwartz L.H., Zucca E., Fisher R.I., Trotman J., Hoekstra O.S., Hicks R.J., O’Doherty M.J., Hustinx R., Biggi A., Cheson B.D. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group // J. Clin. Oncol. 2014. Vol. 32. P. 3048–3058.Tsuji K., Kishi S., Tsuchida T., Yamauchi T., Ikegaya S., Urasaki Y., Fujiwara Y., Ueda T., Okazawa H., Kimura H. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT // J. Magn. Reson. Imaging. 2015. Vol. 41. P. 1601–1607. https://doi.org/10.1002/jmri.24714.Tsuji K., Kishi S., Tsuchida T., Yamauchi T., Ikegaya S., Urasaki Y., Fujiwara Y., Ueda T., Okazawa H., Kimura H. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT // J. Magn. Reson. Imaging. 2015. Vol. 41. P. 1601–1607. https://doi.org/10.1002/jmri.24714.Алгоритмы диагностики и лечения злокачественных новообразований: клинический протокол / Министерство здравоохранения Республики Беларусь. Минск: Профессиональные издания, 2019. 616 с.Algorithms for the diagnosis and treatment of malignant neoplasms: clinical protocol / Ministry of Health of the Republic of Belarus. Minsk: Professional Publications, 2019, 616 p. (In Russ.).Хоружик С.А., Жаврид Э.А., Сачивко Н.В. Диагностическая эффективность диффузионно-взвешенной магнитно-резонансной томографии всего тела при очаговом и диффузном поражении костного мозга у пациентов с лимфомой // Медицинская визуализация. 2017. № 5. C. 66–81. https://doi.org/10.24835/1607-0763-2017-5-66-81.Kharuzhyk S.A., Zhavrid E.A., Sachivko N.V. Diagnostic effectiveness of whole body diffusionweighted magnetic resonance imaging in focal and diffuse bone marrow involvement in patients with lymphoma. Med. Visualiz., 2017, No. 5, рр. 6681 (In Russ.) https://doi.org/10.24835/1607-0763-2017-5-66-81.Hoane B.R., Shields A.F., Porter B.A., Shulman H.M. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging // Blood. 1991. Vol. 78. P. 728–738.Hoane B.R., Shields A.F., Porter B.A., Shulman H.M. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging // Blood. 1991. Vol. 78. P. 728–738.Adams H.J., Kwee T.C., Vermoolen M.A., de Keizer B., de Klerk J.M., Adam J.A., Fijnheer R., Kersten M.J., Stoker J., Nievelstein R.A. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET // Eur. Radiol. 2013. Vol. 23. P. 2271–228. https://doi.org/10.1007/s00330-013-2835-9.Adams H.J., Kwee T.C., Vermoolen M.A., de Keizer B., de Klerk J.M., Adam J.A., Fijnheer R., Kersten M.J., Stoker J., Nievelstein R.A. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET // Eur. Radiol. 2013. Vol. 23. P. 2271–228. https://doi.org/10.1007/s00330-013-2835-9.El Khouli R.H., Macura K.J., Barker P.B., Habba M.R., Jacobs M.A., Bluemke D.A. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast // J. Magn. Reson. Imaging. 2009. Vol. 30. P. 999–1004. https://doi.org/10.1002/jmri.21947.El Khouli R.H., Macura K.J., Barker P.B., Habba M.R., Jacobs M.A., Bluemke D.A. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast // J. Magn. Reson. Imaging. 2009. Vol. 30. P. 999–1004. https://doi.org/10.1002/jmri.21947.Crewson P.E. Reader agreement studies // Am. J. Roentgenol. 2005. Vol. 184. P. 1391–1397.Crewson P.E. Reader agreement studies // Am. J. Roentgenol. 2005. Vol. 184. P. 1391–1397.Padhani A.R., Koh D.M., Collins D.J. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions // Radiology. 2011. Vol. 261. P. 700–718. https://doi.org/10.1148/radiol.11110474.Padhani A.R., Koh D.M., Collins D.J. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions // Radiology. 2011. Vol. 261. P. 700–718. https://doi.org/10.1148/radiol.11110474.Сакович Р.А., Хоружик С.А., Дзюбан А.В., Барановский О.А., Поддубный К.В., Готто С.И., Жаврид Э.А. Интерпретация исследований ФДГ-ПЭТ/КТ всего тела у пациентов с лимфомой после химиотерапии с использованием шкалы Довиль и полуколичественного анализа // Онкологический журнал. 2017. Т. 11, № 3. С. 5–16.Sakovich R.A., Kharuzhyk S.A., Dziuban A.V., Baranovski O.A., Paddubny K.V., Gotto S.I., Zhavrid E.A. Interpretation of whole body FDG-PET/CT examinations in patients with lymphoma after chemotherapy using Deauville scale and semiquantitative analysis. Oncol. J., 2017, Vol. 11, No. 3, рр. 5–16 (In Russ.).Adams H.J.A, Kwee T.C. Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis // Crit. Rev. Oncol. Hematol. 2019. Vol. 141. P. 73–81. https://doi.org/10.1016/j.critrevonc.2019.05.010.Adams H.J.A, Kwee T.C. Proportion of false-positive follow-up FDG-PET scans in lymphoma: Systematic review and meta-analysis // Crit. Rev. Oncol. Hematol. 2019. Vol. 141. P. 73–81. https://doi.org/10.1016/j.critrevonc.2019.05.010.Adams H.J., Nievelstein R.A., Kwee T.C. Prognostic value of complete remission status at end-oftreatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis // Br. J. Haematol. 2015. Vol. 170. P. 185–191. https://doi.org/10.1111/bjh.13420.Adams H.J., Nievelstein R.A., Kwee T.C. Prognostic value of complete remission status at end-oftreatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis // Br. J. Haematol. 2015. Vol. 170. P. 185–191. https://doi.org/10.1111/bjh.13420.Хоружик С.А., Жаврид Э.А., Сачивко Н.В. Диффузионно-взвешенная магнитно-резонансная томография с расчетом измеряемого коэффициента диффузии при мониторинге и раннем прогнозировании регрессии опухолевых очагов в процессе химиотерапии лимфом // Медицинская визуализация. 2015. № 5. С. 83–99.Kharuzhyk S.A., Zhavrid E.A., Sachivko N.V. Diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient measurement for monitoring and early tumor response prediction during lymphoma chemotherapy. Med. Visualiz., 2015, No 5, рр. 83–99 (In Russ.).Toledano-Massiah S., Luciani A., Itti E., Zerbib P., Vignaud A., Belhadj K., Baranes L., Haioun C., Lin C., Rahmouni A. Whole-body diffusion-weighted imaging in Hodgkin lymphoma and diffuse large B-cell lymphoma // Radiographics. 2015. Vol. 35. P. 747–764. https://doi.org/10.1148/rg.2015140145.Toledano-Massiah S., Luciani A., Itti E., Zerbib P., Vignaud A., Belhadj K., Baranes L., Haioun C., Lin C., Rahmouni A. Whole-body diffusion-weighted imaging in Hodgkin lymphoma and diffuse large B-cell lymphoma // Radiographics. 2015. Vol. 35. P. 747–764. https://doi.org/10.1148/rg.2015140145.Younes A., Hilden P., Coiffier B., Hagenbeek A., Salles G., Wilson W. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) // Ann. Oncol. 2017. Vol. 28. P. 1436–1447. https://doi.org/10.1093/annonc/mdx097.Younes A., Hilden P., Coiffier B., Hagenbeek A., Salles G., Wilson W. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017) // Ann. Oncol. 2017. Vol. 28. P. 1436–1447. https://doi.org/10.1093/annonc/mdx097.Bernstine H., Domachevsky L., Nidam M., Goldberg N., Abadi-Korek I., Shpilberg O., Groshar D. 18 F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC) // Medicine (Baltimore). 2018. Vol. 97. e0490. https://doi.org/10.1097/MD.0000000000010490.Bernstine H., Domachevsky L., Nidam M., Goldberg N., Abadi-Korek I., Shpilberg O., Groshar D. 18 F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC) // Medicine (Baltimore). 2018. Vol. 97. e0490. https://doi.org/10.1097/MD.0000000000010490.

The authors declare that there are no conflicts of interest present.